Skip to main content
Equibles

Susquehanna Portfolio Strategies, LLC

Position in RZLT — Rezolute, Inc.

CIK 1996449 Bala Cynwyd, PA
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$1,454,133
+$1,105,430 QoQ
Shares Held
279,641
+144.6% QoQ
Ownership
0.290%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#43
of 144 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Susquehanna Portfolio Strategies, LLC holds $404,884,857 across 122 Biotechnology names. RZLT ranks #55 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 90,928 $45,166,665
2 MRNA
Moderna, Inc.
 471,043 $32,987,141
3 CORT
Corcept Therapeutics Inc
 211,017 $18,347,928
4 BBIO
BridgeBio Pharma, Inc.
 226,869 $16,897,203
5 BMRN
Biomarin Pharmaceutical Inc
 273,562 $15,653,217
6 HALO
Halozyme Therapeutics, Inc.
 166,503 $13,032,189
7 EXEL
Exelixis, Inc.
 229,749 $12,500,643
8 MDGL
Madrigal Pharmaceuticals, Inc.
 22,003 $11,814,510

All Filings in RZLT

Export CSV
2 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,454,133 279,641
2026-03-31 $348,703 114,329